Oklahoma Gov. Kevin Stitt, state legislators and several Oklahoma cities have raised concerns about who would get the $85 million from a settlement the Oklahoma attorney general reached last month with opioid manufacturer Teva Pharmaceuticals Industries Ltd.
In an amicus brief filed Friday, the governor, along with Oklahoma House of Representatives Speaker Charles McCall and the state’s Senate President Pro Tempore Greg Treat, wrote that the Teva settlement did not comply with an Oklahoma law enacted last month that made it “unconstitutional for any settlement agreement to direct how, when or where the legislature appropriates state monies.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
